AIIMS doctor questions the scientific basis of Deepinder Goyal’s temple device, cites lack of clinical proof
Zomato CEO Deepinder Goyal launched the Temple device, a wearable aiming to monitor cerebral blood flow and link it to his Gravity Aging Hypothesis. However, medical professionals like Dr. Suvrankar Datta criticize it as an unproven "fancy toy for billionaires" lacking scientific standing and clinical trials, urging caution for consumers.
Zomato CEO Deepinder Goyal launched the Temple device, a wearable aiming to monitor cerebral blood flow and link it to his Gravity Aging Hypothesis. However, medical professionals like Dr. Suvrankar Datta criticize it as an unproven "fancy toy for billionaires" lacking scientific standing and clinical trials, urging caution for consumers.
